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ABSTRACT 
Clinical microbiologist are facing challenge to defeat the bacterial infections like Methicillin Resistant Staphylococcus aureus (MRSA) in humans; due 
to unique resistance in bacterial strain. There are limited medication options left to conquer this deadly toxicities, if holistic approach is ignored. 
Also the linked complications and consequences of infections may increase beyond threshold levels; if exercise only a single array of drug therapy. 
This research article is based on primary microbial data collection (from sputum, urine and blood) in hospital; where the experiment focuses to 
investigate the highest risk vulnerable area. The preventive and curative measures are discussed along with alternative multiple array of medication 
with prudent selection to achieve targeted and optimum outcome.  
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INTRODUCTION 
Currently, in advanced scientific era of this modern digital age, 
Microbiologists are observing a global hype in infectious human 
diseases through Staphylococcus aureus (S. aureus), which is 
precisely known as Methicillin Sensitive Staphylococcus aureus 
(MSSA). In this, infections of skin are due to the strains (i.e. invasive) 
of Methicillin Resistant Staphylococcus aureus (MRSA). It has a 
capacity to severely resist antibiotics; as experienced in the previous 
decades. These lethal infections are responsible for causing 
significant morbidity for mankind and stress (including both 
economic and financial) upon health care system. This study focuses 
on adopting an ingenious integrated approach to discover the 
effective solution by implementing preventive measures to control 
epidemic, using localized treatment by alternative medicines to cure 
and heal, and to treat the menace of human infections produced by 
MRSA. 
Challenges and Changes 
Today, controlling MRSA is still a clinical challenge faced by 
clinicians across the world. The objective of our study is to find out 
the economical, optimum and convenient methods to treat the 
human infections caused by MRSA. Therefore, the focus of research 
is to consider alternative medicines (such as natural / herbal / 
ayurvedic, homeopathic, Chinese medicines) and modern 
therapeutic methods (such as radio waves, nuclear / radio-active / 
laser therapy) that are essential as well as effective; which not only 
boosts the natural physiological immune system but also efficiently 
diminish the infectious effects and therapeutic side effects. 
Those, who are not involved in health care settings, are very often 
unaware of this silent and lethal epidemic. This lack of awareness 
comprises three folds which is; significance of risk and peril of 
hospital acquired MRSA infections, and their potential threat to 
overall health care system. In order to control the global menace of 
infections, a significant public behavioral change is needed. For this 
behavioral change to occur, a well-informed public is essential. 
Habitat 
As S. aureus is a highly contagious and ubiquitous bacterial species 
found throughout the ecosystem. Here the fatal entry of this 
microorganism starts from invading the skin (or deeper tissues); 
and later it multiplies to increase its population to cause a localized 
or systemic response, as in septicemia (blood poisoning), then a 
patient becomes infected. The hibernation or inactivated time period 
does not mean that it may not contaminate body area; but still it 
multiplies for its quantum population. 
It is predominant in damp health-care environments; also in those 
persons who seem to be weaker, older and sicker than the over-all 
population that enhances the exposure of infection by weaker 
resistance (i.e. immunity). Many individuals either living or 
functioning together closely are the perfect congenial environment 
for the transmission of infectious diseases. It is reported that, 
individuals may carry this infection without having any visible 
indications. 
Causes 
Main cause of microbial resistance is due to the production of β-
lactamase enzyme in the affected area. Some strain of MRSA, termed 
as epidemic strains (EMRSA); however, sixteen EMRSA strain 
variants have been explored in the globe. In recent times, the 
common strain variants to affect hospitals are EMRSA fifteen and 
sixteen. After the development of infection, the choice of antibiotics, 
as efficient and effective remedy is reduced; although they are 
expensive and possibly show harmful side-effects towards the 
patient. Recent evidence supports that household pets; such as cats, 
hens and dogs, can transmit MRSA to their owners. The chart below 
depicts the degree of risk factor sensitivity for bacterial growth: 
 
Fig. 1: The degree of risk factor sensitivity for bacterial growth 
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MATERIAL AND METHODS 
An empirical study was conducted from July to August 2014 at 
Benazir Bhutto Hospital (BBH) previously known as Rawalpindi 
General Hospital (RGH), an 800 bed tertiary teaching hospital 
located in the Rawalpindi city of Pakistan. Firstly, we identified the 
patients and then the data (without the disturbance of routine work 
life) were gathered by using the information and support system 
from the targeted hospital. For this purpose, the collection of 
samples were gathered in containers which were already sterile by 
healthcare team using aseptic technique. The samples were 
transported without any delay for immediate processing. 
Two media (Chocolate and Blood agar) were used for the 
identification and isolation of S. aureus. Then, these collected 
samples were inoculated onto Chocolate agar as well as on Blood 
agar. The two tests used to identify the bacteria type i.e. coagulase 
and oxidase. 
The Chocolate agar plates were incubated in a ten percent (10 %) 
carbon dioxide incubator at 37oC for one day i.e. 24 hours. The Blood 
agar plates were incubated for twenty four to thirty six hours (24 – 
36 hrs.) at 37oC. The particular bacterial characteristics were 
identified by using standard microbiological techniques. 
Methicillin Resistant Staphylococcus aureus was identified by using 
Vancomycin (30 µg) and Gentamicin (10 µg) disks. Inducible 
resistance was identified in S. aureus by disk approximation test. The 
data were documented and then critically analyzed for the 
completion of this study. A reference strain S. aureus MTCC 87 was 
used for the standardization of antibiotic susceptibility testing. 
RESULTS AND DISCUSSION 
 
Fig. 2: Total Collected Samples – Segregated 
872 total samples were processed from both in-patients and out-
patients. The highest rate of S. aureus from the processed samples 
was found in 50 % blood samples; where 3/9 blood-samples were 
males (age bracket in years: 50-60) and 2/9 blood-samples were 
females (age bracket in years: > 60) followed by 33.33 % in urine; 
where each 2/6 urine-samples (age bracket in years: 50-60) found 
both in males and females. However the lowest rate of S. aureus from 
the processed samples was found in sputum samples which is 16.66 
%; where each 1/3 sputum-samples found in males (age bracket in 
years: 50-60 and 40-50) and 1/3 sputum-samples found in females 
(age bracket in years: 30-40). 
 
Fig. 3: Total Samples Contaminated with S. aureus– Segregated 
To conclude, the study showed high prevalence of MRSA among in-
door patients. 
Preventive Measures (Economical and Accessible) 
The following measures are essential to be taken to prevent early 
spread of infectious diseases; and must be taken at all times and also 
among each and every individuals including persons engage with 
them in health care system. 
Appropriate hand washing (including areas between fingers and 
nails) is generally accepted to be the first necessary action used for 
decreasing the infection. Alternatively, alcohol-hand-rub can be 
applied for decontamination. Keep hand cleanliness – with each 
patient contact, replacing bed linen as well as bedding; after 
handling anything contaminated with body fluids, removing 
protective clothing / gloves; prior to aseptic technique, handling 
invasive devices and also before handling food. Also maintain 
cleanliness of general environment including atmosphere (as MRSA 
is both airborne and waterborne disease). Maintain an appropriate 
ratio of staff and patient. Keeping nails clean, short as well as polish 
free; avoid wearing wristwatches specifically finger-rings, is one of 
the best preventive tactical decision. 
Curative Measures 
For mild skin infections, the use of either oral antibiotics or topical 
Mupirocin directed towards common skin flora, is the first line of 
treatment. For less severe infections, topical antibiotics are mostly 
useful. However, MRSA strains are highly resistant to various 
antibiotics, including Cephalosporins, Macrolides and Quinolones. 
The use of systemic antibiotic should be reserved for mild to 
moderate or severe infections that cover a large surface area. The 
use of an antimicrobial agent is highly recommended for the purpose 
of treatment. Antibiotics like Ciprofloxacin, Sulfamethoxazole / 
Trimethoprim, Linezolid, Rifampin or Vancomycin are right options 
for treatment. It is noticed that most of the infections with 
appropriate treatment resolved within ten days; if the symptoms not 
resolved then the right mix of antibiotics / medicines may be tried; 
that can simultaneously defend and destroy the bacterial invasion in 
the body and boost the self-immune system with least side-effects. 
Alternative Medicines 
Herbal drug treatment may be adapted such as turmeric (dried 
rhizome of Curcuma longa belonging to family Zingiberaceae), olive 
leaves extract, and essential oil, such as tea tree oil or lavender oil, 
black drawing salve, bentonite clay ichthammol ointment may be 
applied. Some specialists advise washing the infected area with 
hydrogen peroxide and then applying the bentonite clay. 
Selective range of electromagnetic waves / lasers and radio-nuclear 
therapy may be adopted as localized modern clinical treatment. 
MRSA was detected sensitive towards both solar (Ultraviolet A& B) 
as well as germicidal (Ultraviolet C) ultraviolet radiation (UV – C 
radiation is substantially more lethal). The calculated exposure of UV 
radiation (both solar and germicidal) increases the concentration of 
Sodium Chloride (NaCl) medium; where cells exhibit increase in 
sensitivity. 
The most common homeopathic treatment for MRSA may include 
Pulsatilla and Aconitum (genera in the family of Ranunculaceae); 
and also belladonna (species in the family of Solanaceae). Pulsatilla 
is a homeopathic remedy especially recommended in women and 
children. Aconitum is proven to be helpful in all kinds of the 
infection, including MRSA. In homeopathic doses, belladonna 
remedy (extremely small doses) is also used to cure the red skin, 
often associated with the infections. 
CONCLUSION 
As stated above, the study showed high prevalence of MRSA among 
in-door patients. However, the affected patients can socialize as 
usual; but proper decontamination of hands and use of face mask, 
need to be incorporated. To minimize the extent of infection, health-
care-staff (including attendants and visitors) should make sure that 
they wash their hands with sterile liquid thoroughly between 
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patient’s clinical examinations. Health care associated infection 
(HCAI) should be highlighted prominently on the media at national 
and international level for public awareness and advocacy. 
An integrated drug therapy approach (such as natural / herbal / 
ayurvedic, homeopathic, radio waves, Chinese medicines etc.) should 
be adopted in a strategic way to deplete the cause and effect, and the 
same time to boost the natural physiological immune system 
tactically for targeted optimum outcome. 
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